Simotinib

CAS No. 944258-89-3

Simotinib ( SIM6802;SIM-6802 )

Catalog No. M16764 CAS No. 944258-89-3

Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 258 Get Quote
50MG 1269 Get Quote
100MG 1791 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Simotinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
  • Description
    Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.Lung Cancer Phase 1 Clinical
  • Synonyms
    SIM6802;SIM-6802
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    Cancer
  • Indication
    Lung Cancer

Chemical Information

  • CAS Number
    944258-89-3
  • Formula Weight
    500.95
  • Molecular Formula
    C25H26ClFN4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=C(OCCN2CC3(C4(OCCO4)C2)CC3)C=C(C(NC5=CC=C(F)C(Cl)=C5)=NC=N6)C6=C1
  • Chemical Name
    N-(3-chloro-4-fluorophenyl)-6-(2-(5,8-dioxa-11-azadispiro(2.0.4.3)undec-11-yl)ethoxy)-7-methoxy-4-quinazolinamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Huang L, et al. Anticancer Drugs. 2016 Apr;27(4):300-11.
molnova catalog
related products
  • AZ7550

    AZ7550 is an active metabolite of AZD9291 and inhibits the activity of IGF1R with an IC50 of 1.6 μM.

  • Methyl 2,5-dihydroxy...

    Methyl 2,5-dihydroxycinnamate is an EGF receptor-associated tyrosine kinases inhibitor.

  • EGFR-IN-8

    EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC. EGFR-IN-8 is a dual EGFR and c-Met inhibitor.